Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage

Neuroscience Letters

Volumn 609, Issue , 2015, Pages 109-119

  Li, Dan ^a   Lei, Chunyan ^a   Zhang, Shuting ^a   Zhang, Shihong ^a   Liu, Ming ^a   Wu, Bo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

High mobility group box 1; Inflammation; Intracerebral hemorrhage; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; COLLAGENASE; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 ANTAGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 ANTAGONIST; TOLL LIKE RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; ETHYL PYRUVATE; FPS-ZM1; HBP1 PROTEIN, RAT; PYRUVIC ACID DERIVATIVE; TLR2 PROTEIN, RAT; TLR4 PROTEIN, RAT;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN SIZE; HUMAN; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; DRUG EFFECTS; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; APOPTOSIS; BENZAMIDES; BRAIN; BRAIN EDEMA; CEREBRAL HEMORRHAGE; HMGB1 PROTEIN; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 9; PYRUVATES; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84945130262     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.10.035     Document Type: Article

References (31)

1. Qureshi A.I., Mendelow A.D., Hanley D.F. Intracerebral haemorrhage. Lancet 2009, 373:1632-1644.
2. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., Hanley D.F. Spontaneous intracerebral hemorrhage. New Engl. J. Med. 2001, 344:1450-1460.
3. Elliott J., Smith M. The acute management of intracerebral hemorrhage: a clinical review. Anesth. Analg. 2010, 110:1419-1427.
4. Mayer S.A., Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol. 2005, 4:662-672.
5. Keep R.F., Hua Y., Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012, 11:720-731.
6. Hwang B.Y., Appelboom G., Ayer A., Kellner C.P., Kotchetkov I.S., Gigante P.R., Haque R., Kellner M., Connolly E.S. Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc. Dis. 2011, 31:211-222.
7. Zhou Y., Wang Y., Wang J., Anne Stetler R., Yang Q.W. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog. Neurobiol. 2014, 115:25-44.
8. Lei C., Lin S., Zhang C., Tao W., Dong W., Hao Z., Liu M., Wu B. High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats. Neuroscience 2013, 228:190-199.
9. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 2003, 284:C870-C879.
10. West K.L., Castellini M.A., Duncan M.K., Bustin M. Chromosomal proteins HMGN3a and HMGN3b regulate the expression of glycine transporter 1. Mol. Cell. Biol. 2004, 24:3747-3756.
11. Andersson U. HMGB1 as a DNA-binding cytokine. J. Leukocyte Biol. 2002, 72.
12. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., Salomone S., Moskowitz M.A. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cerebral Blood Flow Metab. Off. J. Int. Soc. Cerebral Blood Flow Metab. 2008, 28:927-938.
13. Hayakawa K., Qiu J., Lo E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. New York Acad. Sci. 2010, 1207:50-57.
14. Zhou Y., Xiong K.L., Lin S., Zhong Q., Lu F.L., Liang H., Li J.C., Wang J.Z., Yang Q.W. Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Med. Inflamm. 2010, 2010.
15. Lei C., Lin S., Zhang C., Tao W., Dong W., Hao Z., Liu M., Wu B. Effects of high-mobility group box1 on cerebral angiogenesis and neurogenesis after intracerebral hemorrhage. Neuroscience 2013, 229:12-19.
16. Lei C., Wu B., Cao T., Zhang S., Liu M. Activation of the high-mobility group Box 1 protein-receptor for advanced glycation end-products signaling pathway in rats during neurogenesis after intracerebral hemorrhage. Stroke J. Cerebral Circ. 2014.
17. Rosenberg G.A., Mun-Bryce S., Wesley M., Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke J. Cerebral Circ. 1990, 21:801-807.
18. Deane R., Singh I., Sagare A.P., Bell R.D., Ross N.T., LaRue B., Love R., Perry S., Paquette N., Deane R.J., Thiyagarajan M., Zarcone T., Fritz G., Friedman A.E., Miller B.L., Zlokovic B.V. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 2012, 122:1377-1392.
19. Garate I., Garcia-Bueno B., Madrigal J.L., Caso J.R., Alou L., Gomez-Lus M.L., Leza J.C. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J. Neuroinflamm. 2014, 11:8.
20. Lu C., Liu L., Chen Y., Ha T., Kelley J., Schweitzer J., Kalbfleisch J.H., Kao R.L., Williams D.L., Li C. TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-Kinase/Akt signaling. J. Immunol. 2011, 187:1458-1466.
21. Swanson Raymond A., Morton Matthew T., Tsao-Wu George, Savalos Robert A., Davidson Charisse, Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cerebral Blood Flow Metab. 1990, 290-293.
22. Cui X., Chopp M., Zacharek A., Karasinska J.M., Cui Y., Ning R., Zhang Y., Wang Y., Chen J. Deficiency of brain ATP-binding cassette transporter A-1 exacerbates blood-brain barrier and white matter damage after stroke. Stroke J. Cerebral Circ. 2015, 46:827-834.
23. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
24. Rouhiainen A., Kuja-Panula J., Tumova S., Rauvala H. RAGE-mediated cell signaling. Methods Mol. Biol. 2013, 963:239-263.
25. Lin L., Zhong K., Sun Z., Wu G., Ding G. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J. Cancer Res. Clin. Oncol. 2012, 138:11-22.
26. Alexiou P., Chatzopoulou M., Pegklidou K., Demopoulos V.J. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr. Med. Chem. 2010, 17:2232-2252.
27. Gu Q., Wang B., Zhang X.F., Ma Y.P., Liu J.D., Wang X.Z. Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats. Eur. J. Pharmacol. 2014.
28. Li H., Wu W., Sun Q., Liu M., Li W., Zhang X.S., Zhou M.L., Hang C.H. Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage. Brain Res. 2014, 1543:315-323.
29. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., Bendszus M., Rossetti G., Nawroth P.P., Bierhaus A., Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci.: Off. J. Soc. Neurosci. 2008, 28:12023-12031.
30. van Zoelen M.A., Yang H., Florquin S., Meijers J.C., Akira S., Arnold B., Nawroth P.P., Bierhaus A., Tracey K.J., van der Poll T. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009, 31:280-284.
31. Ibrahim Z.A., Armour C.L., Phipps S., Sukkar M.B. RAGE and TLRs: relatives, friends or neighbours?. Mol. Immunol. 2013, 56:739-744.